88.24
19.26 (27.92%)
| Previous Close | 68.98 |
| Volume | 3,952,848 |
| Price / Earnings (Forward) | 37.79 |
| Price / Sales | 4.18 |
| Price / Book | 4.86 |
| 52 Weeks Range |
| Profit Margin | 10.03% |
| Operating Margin (TTM) | 19.12% |
| Diluted EPS (TTM) | 1.42 |
| Quarterly Revenue Growth (YOY) | 48.20% |
| Quarterly Earnings Growth (YOY) | 110.60% |
| Total Debt/Equity (MRQ) | 194.67% |
| Current Ratio (MRQ) | 9.10 |
| Operating Cash Flow (TTM) | 49.38 M |
| Levered Free Cash Flow (TTM) | -84.81 M |
| Return on Assets (TTM) | 4.21% |
| Return on Equity (TTM) | 22.99% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | TransMedics Group, Inc. | Mixed | Bullish |
AIStockmoo Score
| Value 35% | 0.9 |
| AI Insight info | NA |
| Relative Valuation info | 2.0 |
| Financial Health info | -0.7 |
| Timing 35% | 2.2 |
| AI Technical info | NA |
| Technical Oscillators info | 2.0 |
| Technical Moving Averages info | 2.5 |
| Smart Money 30% | 0.0 |
| Analyst Consensus info | 0.0 |
| Insider Activity info | 0.0 |
| Environment | ×0.83 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | -6.8% |
| Pillar Agreement | ×1.25 |
| Not in score | |
| Price Volatility info | 3.2 |
| Final Score | 1.14 |
Select this tab to load the latest available analysis.
|
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 3.03% |
| % Held by Institutions | 121.56% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| ARAUJO FERNANDO N. | 66.90 | - | 22,969 | 1,536,626 |
| Aggregate Net Quantity | 22,969 | |||
| Aggregate Net Value ($) | 1,536,626 | |||
| Aggregate Avg. Buy ($) | 66.90 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| ARAUJO FERNANDO N. | Officer | 28 Oct 2026 | Acquired (+) | 22,969 | 66.90 | 1,536,626 |
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |